Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

FT-23 attenuates diastolic dysfunction in model of diabetic cardiomyopathy

Aug. 16, 2010

Iontophoretically delivered terbinafine enters phase II trial in onychomycosis

Aug. 16, 2010

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Aug. 16, 2010

Onabotulinumtoxin A is safe and efficacious in women with vertical lip columns

Aug. 13, 2010

New clindamycin/tretinoin gel more effective than constituents in treating acne

Aug. 13, 2010

Cannabinoids show promise in models of inflammation and bone loss

Aug. 13, 2010

Abobotulinumtoxin A rapidly reduces glabellar lines in phase III trials

Aug. 13, 2010

Ustekinumab yields sustained response in phase II and III trials in plaque psoriasis

Aug. 13, 2010

New models predict activity/selectivity of cannabinoid receptor agonists/antagonists

Aug. 11, 2010

Nabilone shows promise to treat cannabis use disorders

Aug. 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...